Replay available

Itaconix plc (ITX) Q2 2026 Earnings Call

Itaconix plc (LSE: ITX) Q2 2026 earnings conference call, held 2026-09-09. Replay captured from the company's public earnings webcast.

Wed, September 9, 2026 at 6:00 AMendedReplay
Itaconix plc (ITX) Q2 2026 Earnings Call

Investor webinar replay

Meeting Overview The AtconX PLC 2026 half-year results investor presentation focused on the company's financial performance, highlighting record revenues, break-even EBITDA profitability, and growth in various market segments. Key executives discussed the company's strategies for expanding its customer base and product offerings while maintaining profitability. Key Discussion Points - Presentation of record half-year revenues and break-even EBITDA profitability. - Overview of the company's business model and value proposition centered around idaconic acid. - Discussion of growth in different market segments, particularly in North America and EMEA. - Introduction of new customers and increased order volumes from existing customers. - Emphasis on the company's strategy for product development and commercial expansion. Decisions Made - No explicit decisions recorded. Action Items & Next Steps - [Unassigned] : Monitor reorder rates from new EMEA customer to assess potential volume contr...

Latest press releases

Companies on this event

Featured Presenters

John Shaw

CEO

Laura Denner

Chief Financial Officer

Replay transcript excerpt

Speaker 1: Good afternoon and welcome to the AtconX PLC 2026 half-year results investor presentation. Speaker 1: Throughout this recorded presentation, investors will be in listen-only mode. Questions are encouraged and they can be submitted at any time using the Q&A tab situated on the right-hand corner of your screen. Simply type in your questions and press send. Before we begin, I would like to submit the following poll, and I would now like to hand you over to CO John Shaw. Good afternoon to you, sir. Speaker 2: Thank you. Speaker 2: We look forward to going through our results today Speaker 2: and Speaker 2: giving you some overview of what we've done and where we end up, where we'll be going in the near term here. Speaker 2: So we started with a very good 1st 0.5, record half-year revenues, Speaker 2: our 4th 0.5 of revenue growth, excellent commercial Speaker 2: progress. What's most exciting is we achieved our 1st 0.5 of break-even EBITDA profitability. Speaker 2: We expanded our overall revenues to existing customers, we landed new important customers, Speaker 2: and we achieved that break-even profitability Speaker 2: while still investing in new applications, Speaker 2: new products, and key operating improvements. Speaker 2: And we ended the 0.5 of $5 million Speaker 2: to fund continued growth. Speaker 2: If you're new to us on this call or want a quick refresher, we have a very straightforward business and value proposition. Speaker 2: Iodoconic acid is a natural metabolite found in our bodies and nature, Speaker 2: safe and effective. Speaker 2: It's produced at industrial scale by fermentation Speaker 2: using plant-based feedstock from corn. Speaker 2: We purchase it on the open market. We bring it into our U.S. Operations to react it using our paten...

More from Itaconix Plc